Thursday, June 25, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 862 of 1,261

  1. US 8486391

    Cancer treatment kits using antibodies to aminophospholipids

    The Board of Regents of the University of Texas System · Granted Jul 16, 2013 · Expires Jul 11, 2033

    granted

  2. US 8487077

    Simplified one-pot synthesis of [18F]SFB for radiolabeling

    The Regents of the University of California · Granted Jul 16, 2013 · Expires Jul 11, 2033

    granted

  3. US 8487107

    Biphenyl compounds useful as muscarinic receptor antagonists

    Theravance, Inc. · Granted Jul 16, 2013 · Expires Jul 11, 2033

    granted

  4. US 8486410

    RLIP76 liposomes for protection against irradiation

    The Board of Regents of the University of Texas System · Granted Jul 16, 2013 · Expires Jul 11, 2033

    granted

  5. US 8486385

    Methods for therapy of neurodegenerative disease of the brain

    The Regents of the University of California · Granted Jul 16, 2013 · Expires Jul 11, 2033

    granted

  6. US 8486423

    Thermo-kinetic mixing for pharmaceutical applications

    The Board of Regents of the University of Texas System · Granted Jul 16, 2013 · Expires Jul 11, 2033

    granted

  7. US 8486958

    Crystalline forms of a 3-carboxypropyl-aminotetralin compound

    Theravance, Inc. · Granted Jul 16, 2013 · Expires Jul 11, 2033

    granted

  8. US 8486981

    Selective ligands for the dopamine 3 (D3) receptor and methods of using the same

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Jul 16, 2013 · Expires Jul 11, 2033

    granted

  9. US 8486935

    Xinafoate salt of N4-(2,2-difluoro-4H-benzo[1,4]oxazin-3-one)-6-yl]-5-fluoro-N2-[3-(methylaminocarbonylmethyleneoxy)phenyl]2,4-pyrimidinediamine

    Rigel Pharmaceuticals, Inc. · Granted Jul 16, 2013 · Expires Jul 11, 2033

    granted

  10. US 8486928

    Super-oxide dismutase mimetics

    Galera Therapeutics, LLC · Granted Jul 16, 2013 · Expires Jul 11, 2033

    granted

  11. US 8486923

    Use of the combination of ciclesonide and antihistamines for the treatment of allergic rhinitis

    TAKEDA GMBH · Granted Jul 16, 2013 · Expires Jul 11, 2033

    granted

  12. US 8486909

    Compositions and methods for the diagnosis and treatment of inflammatory disorders and fibrotic disease

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Jul 16, 2013 · Expires Jul 11, 2033

    granted

  13. US 8486898

    Compounds and method for inhibiting the activity of gelatinase and collagenase

    China Medical University · Granted Jul 16, 2013 · Expires Jul 11, 2033

    granted

  14. US 8486699

    Immortal unipotent porcine PICM-19H and PICM-19B stem cell lines

    The United States of America, as represented by the Secretary of Agriculture · Granted Jul 16, 2013 · Expires Jul 11, 2033

    granted

  15. US 8486450

    Method of producing solid preparation disintegrating in the oral cavity

    Takeda Pharmaceutical Company Limited · Granted Jul 16, 2013 · Expires Jul 11, 2033

    granted

  16. US 8486428

    Compositions and methods for making and using acyclic N-halamine-based biocidal polymeric materials and articles

    The Board of Regents of the University of Texas System · Granted Jul 16, 2013 · Expires Jul 11, 2033

    granted

  17. US 8486370

    Heterocyclic ligands for integrin imaging and therapy

    The Regents of the University of California · Granted Jul 16, 2013 · Expires Jul 11, 2033

    granted

  18. US 8486989

    Inhibitors of serine proteases, particularly HCV NS3-NS4A protease

    Vertex Pharmaceuticals Incorporated · Granted Jul 16, 2013 · Expires Jul 11, 2033

    granted

  19. US 2013178639

    CRYSTALLINE FORMS OF DIMETHOXY DOCETAXEL AND METHODS FOR PREPARING THE SAME

    AVENTIS PHARMA SA [FR] · Granted Jul 11, 2013 · Expires Jul 6, 2033

    granted

  20. US 8481551

    Gyrase and topoisomerase IV inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Jul 9, 2013 · Expires Jul 4, 2033

    granted

  21. US 8481521

    Methods of treating cell proliferative disorders

    Rigel Pharmaceuticals, Inc. · Granted Jul 9, 2013 · Expires Jul 4, 2033

    granted

  22. US 8481005

    Methods to prevent cytotoxicity using N-acetyl-cysteine

    The Regents of the University of California · Granted Jul 9, 2013 · Expires Jul 4, 2033

    granted

  23. US 8481757

    Compounds and compositions useful in the treatment of malaria

    The Regents of the University of California · Granted Jul 9, 2013 · Expires Jul 4, 2033

    granted

  24. US 8481569

    Iminopyridine derivatives and use thereof

    Takeda Pharmaceutical Company Limited · Granted Jul 9, 2013 · Expires Jul 4, 2033

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.